SCHEMBL6192015

SCHEMBL6192015

CCc1nc(ON2CCNC(CC(C)O)C2)cs1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PRKCQ Q04759 2/20 0.30
PRKCD Q05655 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6193609 0.70 CHRNB4 (0.40)
SCHEMBL6192030 0.69 HPGD (0.34) PRKCQPRKCD
SCHEMBL6028968 0.69 CYP3A4 (0.38)
SCHEMBL6195068 0.67 PRKCQ (0.32) PRKCQPRKCD
SCHEMBL6192023 0.65 ITGA2B (0.33)
SCHEMBL6192472 0.64 ACSL1 (0.43)
SCHEMBL5993548 0.63
SCHEMBL5901443 0.62 POLB (0.46)
SCHEMBL5463927 0.59 LTA4H (0.54)
SCHEMBL5245519 0.59 LTA4H (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583751-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES CV THERAPEUTICS, INC. (US) 2005-10-12 EP disclosed
WO-2004069818-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES CV THERAPEUTICS INC. (US) 2004-08-19 WO disclosed